OSTX
OS Therapies Incorporated Common Stock
$1.840+-0.000 (-0.000%)
Prix en Temps Réel
Graphique des Prix
Loading Chart...
Métriques Clés
Métriques de Marché
Ouverture
$1.840
Haut
$1.840
Bas
$1.840
Volume
0.08M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
PR Newswire
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology...
Voir plus
Analyst Upgrades
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
D. Boral Capital analyst Jason Kolbert maintains OS Therapies with a Buy and maintains $20 price target.
Voir plus
BusinessWire
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented interactions with
Voir plus
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.